Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
出版年份 2021 全文链接
标题
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-01-11
DOI
10.3389/fphar.2020.595635
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease
- (2020) Stephanie Martins de Faria et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes
- (2020) Dan Jin et al. Scientific Reports
- Cannabinoids, Blood–Brain Barrier, and Brain Disposition
- (2020) Fabrizio Calapai et al. Pharmaceutics
- Glial cells in Parkinson´s disease: protective or deleterious?
- (2020) Ana V. Domingues et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Levodopa therapy for Parkinson's disease: history, current status and perspectives
- (2020) Helle Bogetofte et al. CNS & Neurological Disorders-Drug Targets
- Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
- (2020) Agnese Gugliandolo et al. FITOTERAPIA
- Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
- (2020) Paula Morales et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors
- (2020) Carolina Echeverry et al. NEUROTOXICITY RESEARCH
- Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity
- (2019) Éric Samarut et al. Frontiers in Pharmacology
- L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression
- (2019) Naveed Malek et al. PARKINSONISM & RELATED DISORDERS
- Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
- (2019) Xun Zhou et al. Frontiers in Neurology
- What, If, and When to Move: Basal Ganglia Circuits and Self-Paced Action Initiation
- (2019) Andreas Klaus et al. Annual Review of Neuroscience
- A systematic review of cannabidiol dosing in clinical populations
- (2019) S.A. Millar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
- (2019) Hery Chung et al. PLoS One
- The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
- (2019) Shirley Yin-Yu Pang et al. Translational Neurodegeneration
- Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
- (2019) Paolo Calabresi et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease
- (2019) Glauce Crivelaro do Nascimento et al. NEUROPHARMACOLOGY
- The genetics of Parkinson disease
- (2018) Hao Deng et al. AGEING RESEARCH REVIEWS
- Identification of metabolite biomarkers for L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease by metabolomic technology
- (2018) Yong Wang et al. BEHAVIOURAL BRAIN RESEARCH
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
- (2018) Augusta Pisanu et al. JOURNAL OF NEURAL TRANSMISSION
- Levodopa-induced dyskinesia: clinical features, incidence, and risk factors
- (2018) Tai N. Tran et al. JOURNAL OF NEURAL TRANSMISSION
- Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
- (2018) Amanda J. Sales et al. MOLECULAR NEUROBIOLOGY
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands
- (2018) Mireille Alhouayek et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Endocannabinoid-LTP Mediated by CB1 and TRPV1 Receptors Encodes for Limited Occurrences of Coincident Activity in Neocortex
- (2018) Yihui Cui et al. Frontiers in Cellular Neuroscience
- Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
- (2018) Fernanda F. Peres et al. Frontiers in Pharmacology
- Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
- (2018) Gemma Navarro et al. BIOCHEMICAL PHARMACOLOGY
- Cannabinoids in cancer treatment: Therapeutic potential and legislation
- (2018) Barbara Dariš et al. Bosnian Journal of Basic Medical Sciences
- Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors
- (2018) Andreza B. Sonego et al. BRAIN BEHAVIOR AND IMMUNITY
- Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
- (2018) PhilipV Peplow et al. Neural Regeneration Research
- Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials
- (2018) Rajesh Pahwa et al. PARKINSONISM & RELATED DISORDERS
- Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
- (2018) Sara Bachiller et al. Frontiers in Cellular Neuroscience
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus
- (2017) Pedro H Gobira et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- GPR55: A therapeutic target for Parkinson's disease?
- (2017) Marta Celorrio et al. NEUROPHARMACOLOGY
- Endocannabinoid modulation of dopamine neurotransmission
- (2017) Dan P. Covey et al. NEUROPHARMACOLOGY
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
- (2017) Sudhakar R. Subramaniam et al. Frontiers in Aging Neuroscience
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- (2017) Tommaso Cassano et al. Frontiers in Neuroscience
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Adenosine A2A Receptor Modulates the Activity of Globus Pallidus Neurons in Rats
- (2017) Hui-Ling Diao et al. Frontiers in Physiology
- Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
- (2017) Qing-Rong Liu et al. Scientific Reports
- The genetic background of Parkinson's disease: current progress and future prospects
- (2016) K. Kalinderi et al. ACTA NEUROLOGICA SCANDINAVICA
- Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease
- (2016) Marta Celorrio et al. BRAIN BEHAVIOR AND IMMUNITY
- Cannabinoids and Cytochrome P450 Interactions
- (2016) Ondřej Zendulka et al. CURRENT DRUG METABOLISM
- Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration
- (2016) Madeleine J. Swortwood et al. Drug Testing and Analysis
- Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia
- (2016) Dhanya Vijayakumar et al. DRUGS
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study
- (2016) Rodolfo Savica et al. MOVEMENT DISORDERS
- Phytocannabinoids: a unified critical inventory
- (2016) Lumír Ondřej Hanuš et al. NATURAL PRODUCT REPORTS
- Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action
- (2016) Maurício dos-Santos-Pereira et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Astrocytes: Key Regulators of Neuroinflammation
- (2016) Emanuela Colombo et al. TRENDS IN IMMUNOLOGY
- Protective Microglia and Their Regulation in Parkinson’s Disease
- (2016) Weidong Le et al. Frontiers in Molecular Neuroscience
- Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
- (2016) Fernanda F. Peres et al. Frontiers in Pharmacology
- Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia
- (2015) Concepción García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-cannabinoid receptor in the ventral mesencephalon
- (2015) Juliana Almeida da Silva et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson’s Disease Patients in Colorado
- (2015) Taylor Andrew Finseth et al. Evidence-based Complementary and Alternative Medicine
- A mitochondrial superoxide theory for oxidative stress diseases and aging
- (2015) Hiroko P. Indo et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
- (2015) Yu Tang et al. MOLECULAR NEUROBIOLOGY
- Endocannabinoid signalling and the deteriorating brain
- (2015) Vincenzo Di Marzo et al. NATURE REVIEWS NEUROSCIENCE
- Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2015) A.A. Martinez et al. NEUROBIOLOGY OF DISEASE
- Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease
- (2015) María Concepción García et al. NEUROSCIENCE LETTERS
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by l-DOPA?
- (2015) Mariza Bortolanza et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state
- (2015) Adriana Galvan et al. Frontiers in Neuroanatomy
- Activation of GPR18 by cannabinoid compounds: a tale of biased agonism
- (2014) Linda Console-Bram et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease
- (2014) Itay Lotan et al. CLINICAL NEUROPHARMACOLOGY
- Cannabinoids for Neuropathic Pain
- (2014) Perry G. Fine et al. Current Pain and Headache Reports
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease
- (2014) Patrick Oeckl et al. EXPERIMENTAL NEUROLOGY
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Inhibition of Adenylyl Cyclase Type 5 Prevents L-DOPA-Induced Dyskinesia in an Animal Model of Parkinson's Disease
- (2014) H.-Y. Park et al. JOURNAL OF NEUROSCIENCE
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
- (2014) Anthony H V Schapira et al. LANCET
- Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins
- (2014) Patrícia Schönhofen et al. MOLECULAR NEUROBIOLOGY
- Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain
- (2014) Samira S. Valvassori et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Δ9-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18
- (2014) Douglas McHugh et al. Frontiers in Pharmacology
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
- (2013) David Olivares et al. Current Alzheimer Research
- Transport of endocannabinoids across the plasma membrane and within the cell
- (2013) Christopher J. Fowler FEBS Journal
- Striatal CB1and D2receptors regulate expression of each other, CRIP1A and delta opioid systems
- (2013) Lawrence C. Blume et al. JOURNAL OF NEUROCHEMISTRY
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia
- (2013) Matthieu F. Bastide et al. NEUROBIOLOGY OF DISEASE
- Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease
- (2013) Ramiro González-Aparicio et al. NEUROBIOLOGY OF DISEASE
- Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors
- (2013) Francisco Espejo-Porras et al. NEUROPHARMACOLOGY
- Temporal Changes of CB1 Cannabinoid Receptor in the Basal Ganglia as a Possible Structure-Specific Plasticity Process in 6-OHDA Lesioned Rats
- (2013) Gabriela P. Chaves-Kirsten et al. PLoS One
- Functional Neuroanatomy of the Basal Ganglia
- (2013) J. L. Lanciego et al. Cold Spring Harbor Perspectives in Medicine
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Adenosine A2A Antagonists in Parkinson’s Disease: What’s Next?
- (2012) Patrick Hickey et al. Current Neurology and Neuroscience Reports
- A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray
- (2012) C. G. Stott et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Classic and New Animal Models of Parkinson's Disease
- (2012) Javier Blesa et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Δ9-tetrahydrocannabinol (Δ9-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease
- (2012) C. B. Carroll et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease
- (2012) Soosung Kang et al. Nature Communications
- Modulation of Striatal Projection Systems by Dopamine
- (2011) Charles R. Gerfen et al. Annual Review of Neuroscience
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism-Related Genes in Microglial Cells
- (2011) Neta Rimmerman et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Role of Cannabinoids in Multiple Sclerosis
- (2011) John P. Zajicek et al. CNS DRUGS
- Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum
- (2011) Pablo Pandolfo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
- (2011) Y. C. Chung et al. JOURNAL OF IMMUNOLOGY
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease
- (2011) Veronica Francardo et al. NEUROBIOLOGY OF DISEASE
- Contribution of pre-synaptic mechanisms to l-DOPA-induced dyskinesia
- (2011) M. Carta et al. NEUROSCIENCE
- The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats
- (2011) Alex Martinez et al. NEUROSCIENCE RESEARCH
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
- (2011) Tomás González-Hernández Frontiers in Neuroanatomy
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
- (2010) I Magen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
- (2010) Javier Fernández-Ruiz et al. CNS Neuroscience & Therapeutics
- CB1 Cannabinoid Receptors and their Associated Proteins
- (2010) Allyn Howlett et al. CURRENT MEDICINAL CHEMISTRY
- The endocannabinoid system as a target for the treatment of neuronal damage
- (2010) Javier Fernández-Ruiz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
- (2010) Nephi Stella GLIA
- Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-κB activation in BV2 murine microglial cells
- (2010) Young Taek Oh et al. NEUROSCIENCE LETTERS
- The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
- (2010) Felipe V. Gomes et al. PSYCHOPHARMACOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Time-dependent vascular actions of cannabidiol in the rat aorta
- (2009) Saoirse E. O'Sullivan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders
- (2009) Yahya Choonara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
- (2009) Ewa Kozela et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- (2009) Y. Ren et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
- (2009) N. A. Jones et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
- (2008) A. Munoz et al. BRAIN
- The cortico-basal ganglia integrative network: The role of the thalamus
- (2008) Suzanne N. Haber et al. BRAIN RESEARCH BULLETIN
- BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
- (2008) T Foltynie et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Actions of 3-methyl-N-oleoyldopamine, 4-methyl-N-oleoyldopamine and N-oleoylethanolamide on the rat TRPV1 receptor in vitro and in vivo
- (2008) Róbert Almási et al. LIFE SCIENCES
- Biological Functions and Metabolism of Oleoylethanolamide
- (2008) Clémentine Thabuis et al. LIPIDS
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences
- (2007) J M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now